Visiogen, Inc. Launches New Website.New Interactive Educational Website is the Online Home of the Synchrony synchrony /syn·chro·ny/ (-krah-ne) the occurrence of two events simultaneously or with a fixed time interval between them. atrioventricular (AV) synchrony [R] 3-Dimensional Dual Optic Accommodating Intraocular Lens Intraocular lens Lens made of silicone or plastic placed within the eye; can be corrective. Mentioned in: Cataract Surgery IRVINE, Calif. -- Visiogen, Inc. of Irvine, California Irvine is an incorporated city in Orange County, California, United States. It is a planned city, mainly developed by the Irvine Company since the 1960s. Formally incorporated on December 28 1971, the 69.7 square mile (180.5 km²) city has a population of 202,079 (as of 2007). , today announced the launch of its new website, found at www.visiogen.com. This interactive educational website is aimed at introducing both ophthalmologists and patients to the Synchrony[R] 3-dimensional dual optic accommodating intraocular lens (AIOL) and preloaded injector. Features of the website include a library of publications defining the Synchrony technology, surgical footage showing implantation of the lens, and illustrations of the improved visual acuity visual acuity n. Sharpness of vision, especially as tested with a Snellen chart. Normal visual acuity based on the Snellen chart is 20/20. Visual acuity The ability to distinguish details and shapes of objects. the Synchrony system is designed to provide. The site includes an interactive 3-D lens model that lets visitors fully rotate and zoom in on the lens image, allowing them to get acquainted with the dynamic lens structure. Animation, photos and presentation materials demonstrating the attributes of Synchrony and supporting its potential validity are also included on the site. The entire Synchrony system is self-contained and ready for use without the need for lens handling by means of a preloaded injector system. The dual optic lens is designed to be inserted through a 3.6 - 3.8 mm clear-corneal incision. The single-piece 3-dimensional lens unfolds in the eye upon insertion and features two optics connected by a spring system. The springs connect a 5.5-mm high power anterior optic and a 6-mm minus power posterior optic; the spring action moves the front optic and changes the eye's focus from near to far. To date, the Synchrony lens has been implanted in over 800 eyes worldwide. The European CE Mark for the Synchrony[R] Dual Optic Accommodating IOL Noun 1. accommodating IOL - a lens implant containing a hinge that allows for both near and far vision (thus mimicking the natural lens of a young person) accommodating lens implant was received in June of 2006 and post-marketing research studies are currently underway within Europe to further build the scientific foundation for Synchrony. The Synchrony lens is currently an investigational device in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and is being studied in a pivotal clinical trial at 20 sites within the U.S. This study is evaluating the safety and effectiveness of the device and the potential for near, intermediate and distance vision without the use of spectacles in patients post cataract surgery Cataract Surgery Definition Cataract surgery is a procedure performed to remove a cloudy lens from the eye; usually an intraocular lens is implanted at the same time. Purpose The purpose of cataract surgery is to restore clear vision. . About Visiogen Visiogen, Inc. is focused on developing innovative products for cataract and refractive refractive capacity to refract light. refractive error a difference between the focal length of the cornea and lens, and the length of the eye, resulting in myopia or hyperopia. patients. Founded in Irvine, California, in 2001, Visiogen's first commercial application, Synchrony[R], a 3-dimensional dual optic accommodating intraocular lens and pre-loaded injector, is currently in clinical studies in the U.S. and has received the CE Mark in Europe. More information on the company and its offerings can be obtained by contacting: Chuck Brauer or Kate Jennings Maricich Communications for Visiogen, Inc. Tel. 949-223-6455 Fax 949-223-6451 kate@maricich.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion